| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
CHOKSI IMAGING LTD. (BSE: 530427)
530427 Technical Analysis
3
| As on 22nd Apr 2024 530427 SHARE Price closed @ 67.47 and we RECOMMEND Buy for LONG-TERM with Stoploss of 55.10 & Buy for SHORT-TERM with Stoploss of 66.33 we also expect STOCK to react on Following IMPORTANT LEVELS. |
530427SHARE Price
| Open | 66.00 | Change | Price | % |
| High | 67.50 | 1 Day | 0.87 | 1.31 |
| Low | 63.85 | 1 Week | 5.39 | 8.68 |
| Close | 67.47 | 1 Month | 7.62 | 12.73 |
| Volume | 514 | 1 Year | 21.29 | 46.10 |
| 52 Week High 92.00 | 52 Week Low 44.00 | ||||
BSE INDIA Most Active Stocks
| 532822 | 12.89 | -0.23% |
| 512149 | 0.95 | -5.00% |
| 532648 | 25.21 | 5.30% |
| 532775 | 1.75 | 0.00% |
| 532667 | 40.87 | 3.70% |
| 517001 | 0.09 | 12.50% |
| 530557 | 0.72 | 0.00% |
| 511389 | 7.25 | -2.42% |
| 534690 | 7.65 | 4.79% |
| 512379 | 16.86 | -1.11% |
BSE INDIA Top Gainers Stocks
BSE INDIA Top Losers Stocks
| 530427 Daily Charts |
530427 Intraday Charts |
Whats New @ Bazaartrend |
530427 Free Analysis |
|
|
530427 Important Levels Intraday
| RESISTANCE | 74.50 |
| RESISTANCE | 72.25 |
| RESISTANCE | 70.85 |
| RESISTANCE | 69.46 |
| SUPPORT | 65.48 |
| SUPPORT | 64.09 |
| SUPPORT | 62.69 |
| SUPPORT | 60.44 |
530427 Target April 2024
| 4th UP Target | 90.41 |
| 3rd UP Target | 80.5 |
| 2nd UP Target | 74.37 |
| 1st UP Target | 68.24 |
| 1st DOWN Target | 50.76 |
| 2nd DOWN Target | 44.63 |
| 3rd DOWN Target | 38.5 |
| 4th DOWN Target | 28.59 |
530427 Weekly Target
| 4th UP Target | 77.39 |
| 3rd UP Target | 73.93 |
| 2nd UP Target | 71.79 |
| 1st UP Target | 69.65 |
| 1st DOWN Target | 63.55 |
| 2nd DOWN Target | 61.41 |
| 3rd DOWN Target | 59.27 |
| 4th DOWN Target | 55.81 |
530427 Target2024
| 4th UP Target | 113.36 |
| 3rd UP Target | 96.12 |
| 2nd UP Target | 85.46 |
| 1st UP Target | 74.81 |
| 1st DOWN Target | 44.39 |
| 2nd DOWN Target | 33.74 |
| 3rd DOWN Target | 23.08 |
| 4th DOWN Target | 5.84 |
CHOKSI IMAGING LTD. ( BSE INDIA Symbol : 530427 )
Sector : Other And Other Stocks in Same Sector
Sector : Other And Other Stocks in Same Sector
530427 Business Profile
Choksi Imaging Limited manufactures and sells photosensitized materials, medical X-ray films, and other products for the healthcare industry primarily in India. It offers ultrasound and colordropller products, such as cardiovascular, and eSaote compact color and doppler, as well as portable black and white, and other general imaging products; X-ray films and chemicals, which include laser green, laser blue, and laser chemical products; and X-ray accessories, including screens, cassettes, illuminators, and aprons. The company also provides non-destructive testing (NDT) films and chemicals. In addition, it offers NDT services for petrochemical, aerospace, nuclear, and other industrial divisions. Choksi Imaging Limited was founded in 1992 and is based in Mumbai, India. Address: Classique Centre, Mumbai, India, 400093
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service